Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene Hugo Value Type description Network Comparison Type Filtered Interaction Map red green network_comparison
Results: HTML CSV LaTeX Showing element 330 to 379 of 502 in total 
Value Type: Ranked
Network Comparison Type: Divided
Filtered: 0
Interaction Map: High confidence

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
330\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PRAM1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
pram-1 protein; pml-rara target gene encoding an adaptor molecule-1. [source:refseq;acc:nm\_032152]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12320.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
13018.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05668\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
331\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
40s ribosomal protein s3a. [source:swissprot;acc:p49241]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10405.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10992.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05644\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
332\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
myosin heavy chain, cardiac muscle alpha isoform (myhc-alpha). [source:swissprot;acc:p13533]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
8125.5\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
7697.5\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.0556\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
333\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MYH4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
myosin heavy chain, skeletal muscle, fetal (myosin heavy chain iib) (myhc-iib). [source:swissprot;acc:q9y623]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
334\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MYH2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
myosin heavy chain, skeletal muscle, adult 2 (myosin heavy chain iia) (myhc-iia). [source:swissprot;acc:q9ukx2]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
335\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MYH1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
myosin heavy chain, skeletal muscle, adult 1 (myosin heavy chain iix/d) (myhc-iix/d). [source:swissprot;acc:p12882]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
336\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MYH13\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
myosin heavy chain, skeletal muscle, extraocular (myhc-eo). [source:swissprot;acc:q9ukx3]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
337\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
glucosamine--fructose-6-phosphate aminotransferase [isomerizing] 1 (ec 2.6.1.16) (hexosephosphate aminotransferase 1) (d-fructose-6- phosphate amidotransferase 1) (gfat 1) (gfat1). [source:swissprot;acc:q06210]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12953.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
12273.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05541\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
338\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
hydroxyindole o-methyltransferase (ec 2.1.1.4) (hiomt) (acetylserotonin o-methyltransferase) (asmt). [source:swissprot;acc:p46597]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11149.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10571.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0547\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
339\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
tfiih basal transcription factor complex p44 subunit (basic transcription factor 2 44 kda subunit) (btf2-p44) (general transcription factor iih polypeptide 2). [source:swissprot;acc:q13888]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10344.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10903.3\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05406\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
340\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GNAQ\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(q), alpha subunit. [source:swissprot;acc:p50148]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11372.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10792.3\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05374\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
341\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FTHL17\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ferritin heavy polypeptide-like 17. [source:swissprot;acc:q9bxu8]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8702.94\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9169.98\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05366\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
342\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
gaba-a receptor-associated protein. [source:sptrembl;acc:q9by60]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10074\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10609\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05311\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
343\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CSNK1A1L\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
casein kinase i alpha s-like. [source:refseq;acc:nm\_145203]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8356.31\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8788.62\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05173\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
344\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
dihydropyrimidine dehydrogenase [nadp+] precursor (ec 1.3.1.2) (dpd) (dhpdhase) (dihydrouracil dehydrogenase) (dihydrothymine dehydrogenase). [source:swissprot;acc:q12882]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10540.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10027.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05116\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
345\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
alcohol dehydrogenase class iii chi chain (ec 1.1.1.1) (glutathione- dependent formaldehyde dehydrogenase) (ec 1.2.1.1) (fdh). [source:swissprot;acc:p11766]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11563.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
12151.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05086\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
346\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RRN3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
rna polymerase i transcription factor rrn3. [source:refseq;acc:nm\_018427]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9267.81\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9736.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05054\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
347\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CPE\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
carboxypeptidase h precursor (ec 3.4.17.10) (cph) (carboxypeptidase e) (cpe) (enkephalin convertase) (prohormone processing carboxypeptidase). [source:swissprot;acc:p16870]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7670\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7311\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0491\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
348\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MAGED4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
melanoma antigen, family d, 4 isoform 1; mage1 protein; mage-e1 protein; maged4 protein. [source:refseq;acc:nm\_030801]\vspace{3pt}}&\multirow{17}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
16321\vspace{3pt}}}&\multirow{17}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
15577\vspace{3pt}}}&\multirow{17}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.04776\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
349\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
melanoma-associated antigen 3 (mage-3 antigen) (antigen mz2-d). [source:swissprot;acc:p43357]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
350\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MAGEA11\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
melanoma-associated antigen 11 (mage-11 antigen). [source:swissprot;acc:p43364]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
351\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MAGEA2B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
melanoma-associated antigen 2 (mage-2 antigen). [source:swissprot;acc:p43356]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
352\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
hepatocellular carcinoma-associated protein hca1. [source:refseq;acc:nm\_020932]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
353\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MAGEA6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
melanoma-associated antigen 6 (mage-6 antigen) (mage3b). [source:swissprot;acc:p43360]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
354\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MAGED1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
melanoma-associated antigen d1 (mage-d1 antigen) (neurotrophin receptor-interacting mage homolog) (pro2292). [source:swissprot;acc:q9y5v3]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
355\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MAGEF1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
melanoma-associated antigen f1 (mage-f1 antigen). [source:swissprot;acc:q9hay2]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
356\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
melanoma-associated antigen 4 (mage-4 antigen) (mage-x2) (mage-41). [source:swissprot;acc:p43358]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
357\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MAGEA9\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
melanoma-associated antigen 9 (mage-9 antigen). [source:swissprot;acc:p43362]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
358\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MAGEA8\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
melanoma-associated antigen 8 (mage-8 antigen). [source:swissprot;acc:p43361]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
359\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MAGEC1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
melanoma-associated antigen c1 (mage-c1 antigen) (cancer-testis antigen ct7). [source:swissprot;acc:o60732]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
360\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MAGEA4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
melanoma-associated antigen 12 (mage-12 antigen) (mage12f). [source:swissprot;acc:p43365]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
361\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
melanoma-associated antigen 1 (mage-1 antigen) (antigen mz2-e). [source:swissprot;acc:p43355]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
362\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MAGEA10\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
melanoma-associated antigen 10 (mage-10 antigen). [source:swissprot;acc:p43363]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
363\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MAGEB4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
melanoma-associated antigen b1 (mage-b1 antigen) (mage-xp antigen) (dss-ahc critical interval mage superfamily 10) (dam10). [source:swissprot;acc:p43366]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
364\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MAGED2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
melanoma-associated antigen d2 (mage-d2 antigen) (breast cancer associated gene 1 protein) (bcg-1) (11b6) (hepatocellular carcinoma associated protein jcl-1). [source:swissprot;acc:q9unf1]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
365\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
E2F2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
transcription factor e2f2 (e2f-2). [source:swissprot;acc:q14209]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7769.96\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8139.71\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04759\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
366\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
glycine dehydrogenase [decarboxylating], mitochondrial precursor (ec 1.4.4.2) (glycine decarboxylase) (glycine cleavage system p- protein). [source:swissprot;acc:p23378]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8614.89\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9017.27\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04671\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
367\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
f-actin capping protein alpha-2 subunit (capz alpha-2). [source:swissprot;acc:p47755]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
13801.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
13185.9\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0467\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
368\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
adapter-related protein complex 1 sigma 1b subunit (sigma-adaptin 1b) (adaptor protein complex ap-1 sigma-1b subunit) (golgi adaptor ha1/ap1 adaptin sigma-1b subunit) (clathrin assembly protein complex 1 sigma- 1b small chain) (sigma 1b subunit of ap-1 clathrin) (dc22). [source:swissprot;acc:p56377]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
16679.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
15940.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04633\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
369\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
4-aminobutyrate aminotransferase, mitochondrial precursor (ec 2.6.1.19) (gamma-amino-n-butyrate transaminase) (gaba transaminase) (gaba aminotransferase) (gaba-at) (gaba-t). [source:swissprot;acc:p80404]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
18849.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
19704.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04536\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
370\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PDHA2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
pyruvate dehydrogenase e1 component alpha subunit, testis-specific form, mitochondrial precursor (ec 1.2.4.1) (pdhe1-a type ii). [source:swissprot;acc:p29803]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
13652.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
13061\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0453\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
371\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SMARCC2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
swi/snf-related matrix-associated actin-dependent regulator of chromatin c2 isoform a; mammalian chromatin remodeling complex brg1-associated factor 170; chromatin remodeling complex baf170 subunit; swi3-like protein; swi/snf complex 170 kda subunit. [source:refseq;acc:nm\_003075]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
13247.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
12674.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04527\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
372\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
dead (asp-glu-ala-asp) box polypeptide 47; hqp0256 protein. [source:refseq;acc:nm\_016355]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11869.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
12402.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04489\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
373\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
mitogen-activated protein kinase kinase kinase 5 (ec 2.7.1.-) (mapk/erk kinase kinase 5) (mek kinase 5) (mekk 5) (apoptosis signal- regulating kinase 1) (ask-1). [source:swissprot;acc:q99683]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10598.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
11061.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04371\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
374\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CAPS\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
calcyphosine. [source:swissprot;acc:q13938]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9874.54\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9478.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04183\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
375\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TAF9B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
tbp-associated factor 9l; neuronal cell death-related protein; taf9-like rna polymerase ii, tata box binding protein (tbp)-associated factor, 31 kd; neuronal cell death-related gene in neuron-7; transcription associated factor tafii31l; transcription initiation factor iid, 31kd subunit. [source:refseq;acc:nm\_015975]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
14247.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
13686.9\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04097\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
376\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
UQCRC1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ubiquinol-cytochrome c reductase complex core protein i, mitochondrial precursor (ec 1.10.2.2). [source:swissprot;acc:p31930]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10284.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10695.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03993\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
377\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ITGB3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
integrin beta-3 precursor (platelet membrane glycoprotein iiia) (gpiiia) (cd61 antigen). [source:swissprot;acc:p05106]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
14512.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
13958.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0397\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
378\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DCHS1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
protocadherin 16 precursor (cadherin 19) (cadherin fibroblast 1). [source:swissprot;acc:q96jq0]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
19713.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
18962.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0396\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
379\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PSMD10\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 10 (26s proteasome regulatory subunit p28) (gankyrin). [source:swissprot;acc:o75832]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11228.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10806\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03909\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the HGNC identifier if it exists

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/